Through monitoring and dosing guidelines, provider education and training and better alternatives for patient pain management, medical group reduces monthly average of written pain medicine prescriptions by 20 percent, while the number of providers within the medical group grew by 22 percent and the number of patients grew by 12 percent.
Category: From Newswise – Substance Abuse
Texas Tech, Brazilian Researchers Examine Effects of Toxic Stress on Children’s Brain Development
The study uses fMRI data to compare brain development between children who experience pervasive, continuing trauma and those with “normal” development.
Scripps Florida Scientists Identify Novel Compound to Alleviate Pain and Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a possible drug candidate that suppresses pain and itch in animal models.
Lower-Than-Recommended Methadone Doses for Opiate Addiction Are More Likely at Facilities Managed by African-American Directors, Johns Hopkins Study Shows
While the daily dose of methadone for opiate addiction has declined in recent years, facilities run by African-American directors were more likely to provide low methadone doses than facilities run by managers of other races and ethnicities.
TSRI Scientists Develop Vaccine Against Fatal Prescription Opioid Overdose
Scientists at The Scripps Research Institute (TSRI) have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone (oxy) and hydrocodone (hydro) in animal models.
UAB Physician Calls for Better Understanding, Policy and Treatment for Opioid Addiction
Stefan Kertesz, M.D., says a better understanding of what caused and what sustains the opioid epidemic is needed among policymakers and physicians to best serve patients and address the crisis.
Virginia Tech Addiction Expert Lauds Surgeon General’s Report on Substance Use Disorders, Calls for Treatment Reform
Expert on Opioid Addiction Available to Discuss Surgeon General Report of Substance Abuse
A FAAH Better Thing for Cannabis Users: New Insights May Aid Development of Treatments for Cannabis Use Disorder
– A new paper in Biological Psychiatry reports that chronic cannabis users have reduced levels of an enzyme called fatty acid amide hydrolase (FAAH). The enzyme has been considered for treatment for cannabis dependence because it breaks down substances made in the brain that have cannabis-like effects, called endocannabinoids, rendering them inactive.
Research Links Sleep Habits to Adolescent Drug and Alcohol Use
A study led by researchers from the Department of Psychiatry at the University of Pittsburgh School of Medicine and Pitt Department of Psychology has identified a possible link between adolescent sleep habits and early substance abuse. The study, published today in the journal Drug and Alcohol Dependence, found that both sleep duration and sleep quality during late childhood predict alcohol and cannabis use later in adolescence.